Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced that the Company will present at and/or participate in the following virtual investor conferences in May and June:
– RBC 2020 Capital Markets Global Healthcare Conference on May 19-20, 2020
– SVB Leerink CybeRx Series: Digital Health – Innovators & Disruptors on May 21, 2020
– Jefferies 2020 Healthcare Conference on June 2-4, 2020
Investors attending the conferences who would like to schedule one-on-one meetings with Click executives can do so by contacting Ross Muken.
About Click Therapeutics
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. For more information, visit ClickTherapeutics.com.